Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use

Details for Australian Patent Application No. 2002248256 (hide)

Owner Applied Molecular Evolution, Inc. University of Nebraska Medical Center

Inventors Lockridge, Oksana; Pancook, James, D.; Watkins, Jeffry, D.

Agent Spruson & Ferguson

Pub. Number AU-B-2002248256

PCT Pub. Number WO2002/064796

Priority 10/032,233 20.12.01 US; 09/748,739 26.12.00 US

Filing date 21 December 2001

Wipo publication date 28 August 2002

Acceptance publication date 28 September 2006

International Classifications

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

A61K 38/46 (2006.01) Medicinal preparations containing peptides

C12N 9/18 (2006.01) Enzymes, e.g. ligases (6.) - Carboxylic ester hydrolases

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248256

28 September 2006 Application Accepted

  Published as AU-B-2002248256

25 January 2007 Standard Patent Sealed

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248257-Primers and methods for the detection and discrimination of nucleic acids

2002248255-1X2 OPTICAL WAVELENGTH ROUTER